The Effect of Some Symptoms and Features During the Infection Period on the Level of Anxiety and Depression of Adults after Recovery from COVID-19

ArticleAçık Erişim

Özet

Background: Considering the previous evidence regarding SARS/MERS outbreaks, ıt is expected that emergent psychiatric conditions such as mood disorders, anxiety, and depression disorders may occur in survivors of COVID-19. Objectives: In this study, the effects of clinical/neurological symptoms and sociodemographic characteristics of COVID-19 patients during the infection period on the level of anxiety/depression after recovery were investigated. Methods: Firstly, the socio-demographic characteristics of the participants and their clinical/neurological symptoms during the infection period were determined. In addition, the Beck anxiety/depression scale was administered to the participants upon discharge. Then, the odds ratio of the variables was calculated by applying the Poisson regression method to determine the predictors affecting the level of anxiety/depression. Results: In this study, the clinical/neurological symptoms and the sociodemographic characteristics affecting the level of anxiety/depression were found to be associated with adults (mean age 45-years). The number of days of hospitalization was the only clinical feature that increased both anxiety and depression levels. In addition, post-discharge sleep disorder, headache, and alcohol use were found to be predictors of increased anxiety levels. In addition, smoking, the presence of a person with COVID-19 infection in the immediate vicinity, traveling in the last month before the illness, fever, and loss of smell during the infection period was found to increase the level of depression. Moreover, asthma was the only significant comorbidity that increased the anxiety level, while diabetes was the only comorbidity that increased the depression level. Conclusion: It is expected that this study will support social-psychological intervention and have some effects on reducing depressive/anxiety symptoms, which can vary widely in adults during stressful events. © 2022 Bentham Science Publishers.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12985Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorHuyut, Mehmet Tahir
dc.contributor.authorKocatürk, İdris
dc.date.accessioned2026-10-18T20:27:50.282412981Z
dc.date.available2026-10-18T20:27:50.282412981Z
dc.date.issued2022
dc.description.abstractBackground: Considering the previous evidence regarding SARS/MERS outbreaks, ıt is expected that emergent psychiatric conditions such as mood disorders, anxiety, and depression disorders may occur in survivors of COVID-19. Objectives: In this study, the effects of clinical/neurological symptoms and sociodemographic characteristics of COVID-19 patients during the infection period on the level of anxiety/depression after recovery were investigated. Methods: Firstly, the socio-demographic characteristics of the participants and their clinical/neurological symptoms during the infection period were determined. In addition, the Beck anxiety/depression scale was administered to the participants upon discharge. Then, the odds ratio of the variables was calculated by applying the Poisson regression method to determine the predictors affecting the level of anxiety/depression. Results: In this study, the clinical/neurological symptoms and the sociodemographic characteristics affecting the level of anxiety/depression were found to be associated with adults (mean age 45-years). The number of days of hospitalization was the only clinical feature that increased both anxiety and depression levels. In addition, post-discharge sleep disorder, headache, and alcohol use were found to be predictors of increased anxiety levels. In addition, smoking, the presence of a person with COVID-19 infection in the immediate vicinity, traveling in the last month before the illness, fever, and loss of smell during the infection period was found to increase the level of depression. Moreover, asthma was the only significant comorbidity that increased the anxiety level, while diabetes was the only comorbidity that increased the depression level. Conclusion: It is expected that this study will support social-psychological intervention and have some effects on reducing depressive/anxiety symptoms, which can vary widely in adults during stressful events. © 2022 Bentham Science Publishers.
dc.identifier.doi10.2174/2666082218666220325105504
dc.identifier.eissn2666-0830
dc.identifier.endpage163
dc.identifier.issn2666-0822
dc.identifier.issue2
dc.identifier.scopus2-s2.0-85135495102
dc.identifier.startpage151
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12985
dc.identifier.volume18
dc.identifier.wosWOS:000912120300006
dc.language.isoen
dc.publisherBentham Science Publishers
dc.relation.ispartofCurrent Psychiatry Research and Reviews
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectanxiety disorders
dc.subjectCOVID-19
dc.subjectdepression
dc.subjectpoisson regression models
dc.subjectSARS-Cov-2
dc.subjectadult
dc.subjectaged
dc.subjectageusia
dc.subjectalcohol consumption
dc.subjectanosmia
dc.subjectanxiety disorder
dc.subjectArticle
dc.subjectasthma
dc.subjectBeck Anxiety Inventory
dc.subjectBeck Depression Inventory
dc.subjectchronic obstructive lung disease
dc.subjectcigarette smoking
dc.subjectclinical feature
dc.subjectcomorbidity
dc.subjectcoronavirus disease 2019
dc.subjectcross-sectional study
dc.subjectdiabetes mellitus
dc.subjectdisease severity
dc.subjectdizziness
dc.subjectfemale
dc.subjectfever
dc.subjectheadache
dc.subjecthearing impairment
dc.subjecthospital discharge
dc.subjecthospitalization
dc.titleThe Effect of Some Symptoms and Features During the Infection Period on the Level of Anxiety and Depression of Adults after Recovery from COVID-19
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus7
rdl.citation.wos7
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.wos.indexEmerging Sources Citation Index (ESCI)